Park Yoon-Sung, Hong Sung-Jin, Boo Yoo-Kyung, Hwang Eun-Suk, Kim Hyun Jung, Cho Seung-Hee, Na Kyung-In, Cho En-Hi, Shin Sang-Sook
Division of HIV and TB Control, Korea Centers for Disease Control and Prevention, Cheongwon, Korea.
Tuberc Respir Dis (Seoul). 2012 Jul;73(1):48-55. doi: 10.4046/trd.2012.73.1.48. Epub 2012 Jul 31.
The epidemiology of tuberculosis (TB) has been assessed based on the data of the analysis of TB patients notified to the surveillance system in Korea. However, the national status of TB is not validated through this surveillance system. The objective is to determine the epidemiology of TB and to understand the accurate status of TB patients treated in private institutions.
Medical records of 53,579 patients who had been diagnosed with TB in 2008 were analyzed.
Among 53,579 patients, the number of sputum smear positive cases was 15,639(29.2%) and the number of new cases was 39,191 (73.1%). The drug resistance rate of new cases was 5.3%, while the rate stood at 13.3% for TB patients with treatment history. The number of multi-drug resistant TB (MDR-TB) patients was 2,472 (4.6%), which consists of 2.9% of new cases and 9.3% of TB patients with prior treatment history. The number of extensively drug-resistant TB patients was 749 (1.4%), consisting of 1.1% of new cases and 2.2% of TB patients with prior treatment history. In terms of treatment outcomes, 66.4% of all TB patients, 70.5% of new cases, 64.4% of relapse cases, and 46.8% of MDR-TB cases were cured or completed. It was inferred that in 2008, the total number of TB patients reached 70,767, 145.6 per 100,000 people (95% confidence interval, 145.5~145.7).
We conclude that the medical records review of the Health Insurance Review and Assessment Service (HIRA) data can be very effective in promoting the understanding of the current status of TB in private institutions.
韩国已根据向监测系统报告的结核病（TB）患者分析数据评估了结核病的流行病学情况。然而，该国结核病的实际状况并未通过该监测系统得到验证。目的是确定结核病的流行病学情况，并了解在私立机构接受治疗的结核病患者的准确状况。
对2008年被诊断为结核病的53579例患者的病历进行了分析。
在53579例患者中，痰涂片阳性病例数为15639例（29.2%），新发病例数为39191例（73.1%）。新发病例的耐药率为5.3%，而有治疗史的结核病患者的耐药率为13.3%。耐多药结核病（MDR-TB）患者数为2472例（4.6%），其中新发病例占2.9%，有既往治疗史的结核病患者占9.3%。广泛耐药结核病患者数为749例（1.4%），其中新发病例占1.1%，有既往治疗史的结核病患者占2.2%。就治疗结果而言，所有结核病患者中有66.4%、新发病例中有70.5%、复发病例中有64.4%以及耐多药结核病例中有46.8%被治愈或完成治疗。据推测，2008年结核病患者总数达70767例，每10万人中有145.6例（95%置信区间，145.5~145.7）。
我们得出结论，对健康保险审查与评估服务（HIRA）数据进行病历审查对于增进对私立机构中结核病现状的了解可能非常有效。
